Charter Trust Co. Has $2.76 Million Position in Danaher Co. (DHR)

Charter Trust Co. lowered its holdings in Danaher Co. (NYSE:DHR) by 5.3% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 25,438 shares of the conglomerate’s stock after selling 1,430 shares during the quarter. Charter Trust Co.’s holdings in Danaher were worth $2,764,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. BlackRock Inc. increased its stake in Danaher by 0.9% in the third quarter. BlackRock Inc. now owns 43,427,529 shares of the conglomerate’s stock valued at $4,718,836,000 after acquiring an additional 396,818 shares during the period. FMR LLC boosted its position in Danaher by 3.5% in the third quarter. FMR LLC now owns 21,739,751 shares of the conglomerate’s stock valued at $2,362,241,000 after buying an additional 728,725 shares in the last quarter. Putnam Investments LLC boosted its position in Danaher by 0.8% in the second quarter. Putnam Investments LLC now owns 6,385,003 shares of the conglomerate’s stock valued at $630,072,000 after buying an additional 51,596 shares in the last quarter. Flossbach Von Storch AG boosted its position in Danaher by 3.2% in the third quarter. Flossbach Von Storch AG now owns 5,729,830 shares of the conglomerate’s stock valued at $622,603,000 after buying an additional 180,025 shares in the last quarter. Finally, Brown Advisory Inc. boosted its position in Danaher by 3.1% in the third quarter. Brown Advisory Inc. now owns 5,264,409 shares of the conglomerate’s stock valued at $572,030,000 after buying an additional 160,410 shares in the last quarter. 77.13% of the stock is currently owned by institutional investors and hedge funds.

Shares of DHR stock opened at $104.86 on Friday. Danaher Co. has a 1 year low of $91.84 and a 1 year high of $110.86. The company has a market cap of $74.51 billion, a PE ratio of 24.00, a P/E/G ratio of 2.05 and a beta of 1.06. The company has a current ratio of 1.53, a quick ratio of 1.08 and a debt-to-equity ratio of 0.38.



Danaher (NYSE:DHR) last announced its earnings results on Thursday, October 18th. The conglomerate reported $1.10 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.07 by $0.03. Danaher had a net margin of 14.07% and a return on equity of 11.59%. The company had revenue of $4.85 billion for the quarter, compared to analyst estimates of $4.80 billion. During the same period in the prior year, the business earned $1.00 earnings per share. Danaher’s quarterly revenue was up 7.2% on a year-over-year basis. Research analysts predict that Danaher Co. will post 4.51 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Friday, January 25th. Stockholders of record on Friday, December 28th will be given a dividend of $0.16 per share. The ex-dividend date of this dividend is Thursday, December 27th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.61%. Danaher’s payout ratio is 15.88%.

A number of equities analysts have commented on the stock. Robert W. Baird reduced their price target on shares of Danaher from $116.00 to $114.00 and set an “outperform” rating on the stock in a research report on Friday, October 19th. Morgan Stanley boosted their price target on shares of Danaher from $122.00 to $126.00 and gave the company an “overweight” rating in a research report on Wednesday, October 10th. Finally, Zacks Investment Research lowered shares of Danaher from a “buy” rating to a “hold” rating in a research report on Friday, October 12th. One investment analyst has rated the stock with a hold rating and fifteen have issued a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus price target of $112.14.

In other news, insider William King sold 53,433 shares of the company’s stock in a transaction that occurred on Monday, November 5th. The shares were sold at an average price of $101.64, for a total transaction of $5,430,930.12. Following the transaction, the insider now directly owns 36,425 shares in the company, valued at $3,702,237. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Donald J. Ehrlich sold 10,578 shares of the company’s stock in a transaction that occurred on Tuesday, October 23rd. The stock was sold at an average price of $95.77, for a total transaction of $1,013,055.06. Following the transaction, the director now owns 105,491 shares in the company, valued at $10,102,873.07. The disclosure for this sale can be found here. Insiders have sold 150,007 shares of company stock worth $15,202,163 over the last quarter. 11.90% of the stock is owned by company insiders.

COPYRIGHT VIOLATION NOTICE: This piece of content was first reported by Dakota Financial News and is owned by of Dakota Financial News. If you are reading this piece of content on another publication, it was stolen and reposted in violation of US and international trademark and copyright legislation. The correct version of this piece of content can be viewed at https://dakotafinancialnews.com/2018/12/07/charter-trust-co-has-2-76-million-position-in-danaher-co-dhr.html.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.

Featured Story: Put Option

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply